In a study by Hsieh et al., auranofin not only suppressed NRF2 signaling but also enhanced CD8+ T-cell infiltration and improved responsiveness to anti-PD-1 checkpoint blockade in HNSCC [33]. Here, NFE2L2 is linked to head and neck squamous cell carcinoma.